Trial Profile

Irish Personalised Approach to the Treatment of Haemophilia (iPATH) study

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 19 Mar 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Octocog alfa (Primary)
Indications Haemophilia A
Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
Acronyms iPATH

Most Recent Events

06 Feb 2019 According to a Takeda media release, results from this trial will be presented at the 12th Annual Congress of the European Association of Haemophilia and Allied Disorders (EAHAD).
21 Jan 2019 New trial record
04 Dec 2018 Results presented at the 60th Annual Meeting and Exposition of the American Society of Hematology

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com